Volt Active Data connaît une croissance explosive

La plateforme de données éprouvée répond aux besoins en matière de données en temps réel et de prise de décision contextuelle

BEDFORD, Massachusetts, 14 juin 2022/PRNewswire/ — Volt Active Data est la principale plateforme de données d’entreprise construite pour permettre la prise de décision rapide en matière de données. Elle a annoncé aujourd’hui une croissance exceptionnelle de ses activités grâce à l’expansion des comptes clés et à l’acquisition de nouveaux clients utilisant la technologie Volt pour profiter pleinement du monde de la 5G et des données rapides.

Volt Active Data Logo

Volt a vu son chiffre d’affaires augmenter de plus de 100 % au cours des 12 derniers mois, avec des clients importants comme Amdocs et Dream11 qui ont considérablement étendu leur utilisation de la plateforme Volt pour soutenir leur propre croissance par le développement de nouvelles applications. La technologie de Volt touche désormais plus de 2 milliards de personnes dans le monde chaque jour.

« Nous avons rencontré un élan encore plus grand au cours du premier semestre de 2022 », a déclaré David Flower, PDG de Volt. « Associés en grande partie aux énormes opportunités que la convergence de technologies disruptives telles que la 5G, la périphérie et l’IoT présente pour les entreprises disposant de la bonne technologie, nous avons connu une croissance commerciale impressionnante. Cet élan continu est soutenu par un taux de fidélisation exceptionnel et constant de 96 %, qui prouve la valeur que nos clients obtiennent avec notre technologie. »

Points forts. Dream11 de Dream Sports, la plus grande application de sport fantastique au monde avec plus de 130 millions d’utilisateurs actifs, a fait appel à Volt pour soutenir la saison 2022 de l’IPL . Volt a également procédé à un certain nombre d’embauches clés, la plus récente étant celle d’un nouveau responsable des alliances mondiales, chargé d’accélérer le développement des partenariats mondiaux de l’entreprise.

« Nous sommes en train d’écrire le prochain chapitre de notre voyage », a déclaré Flower. « Nous connaissons une croissance record et ce n’est pas surprenant, car notre technologie a été conçue précisément pour ce moment… où la convergence de la 5G, de l’IoT et de l’informatique de périphérie impose des demandes massives en temps réel aux entreprises et à leurs environnements technologiques. »

À propos de Volt Active Data

Volt Active Data permet aux applications d’entreprise d’ingérer, de traiter et d’agir sur les données en quelques millisecondes pour exploiter de nouvelles sources de revenus et prévenir les pertes de revenus. Possédant d’importants clients dans les télécommunications, la finance, les jeux et bien d’autres secteurs verticaux, la plateforme de données VoltDB est idéalement positionnée pour être la technologie de référence de toute entreprise cherchant à tirer pleinement parti de la 5G, de l’IoT et de tout ce qui suivra.

Logo : https://mma.prnewswire.com/media/1805076/Volt_Active_Data_Logo.jpg

Volt Active Data Sees Explosive Growth

Proven Data Platform Capitalizes on Need for Real-Time Data and Contextual Decisioning

BEDFORD, Mass., June 14, 2022 /PRNewswire/ — Volt Active Data, the leading enterprise-grade data platform built to enable fast-data decisioning, today announced exceptional growth in business driven by expansion in key accounts and the acquisition of new customers leveraging Volt technology to take full advantage of the 5G and fast-data world.

Volt Active Data Logo

Volt has seen a more than 100 percent revenue increase over the past 12 months, with major customers such as Amdocs and Dream11 significantly expanding their use of Volt’s platform to support their own growth through the development of new applications. Volt technology now touches the lives of more than 2 billion people worldwide each day.

“We have encountered even greater momentum in the first half of 2022,” said Volt CEO David Flower. “Associated in large part to the huge opportunities that the convergence of disruptive technologies such as 5G, edge, and IoT presents to companies with the right technology in place, we’ve experienced impressive business growth. This continued momentum is supported by an exceptional and consistent 96 percent retention rate, which proves the value that our customers achieve with our technology.”

Among the highlights. Dream Sports’ Dream11, the world’s largest fantasy sports app with more than 130 million active users, tapped Volt to support the IPL 2022 season. Volt has also made a number of key new hires, the most recent being a new Head of Global Alliances to accelerate the company’s expanding global partnerships.

“We are writing the next chapter of our journey,” Flower said. We’re growing at record pace and it’s no surprise because our technology was designed precisely for this moment… when the convergence of 5G, IoT, and edge computing are placing massive real-time demands on companies and their technology environments.

About Volt Active Data

Volt Active Data empowers enterprise-grade applications to ingest, process, and act on data in single-digit milliseconds to tap into new revenue streams and prevent revenue loss. With industry-leading customers in telecommunications, finance, gaming, and many other verticals, The VoltDB Data Platform is uniquely positioned to be the go-to technology for any company seeking to take full advantage of 5G, IoT, and whatever comes next.

Logo – https://mma.prnewswire.com/media/1805076/Volt_Active_Data_Logo.jpg

Impulse Dynamics Announces First International Implants of the Optimizer Smart Mini System in Italy

MARLTON, N.J., June 14, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a commercial-stage medical device company focused on delivering our CCM therapy to people with heart failure, announced that the first implants in Europe for the newly launched Optimizer® Smart Mini device were recently completed in Italy. The company announced the launch of the new technology on April 29, 2022, and the first U.S. implants on May 10, 2022.

Dr. Stefano Guarracini, Head of Cardiology at the Synergo Casa di Cura Pierangeli Hospital in Pescara, Italy, described his experience with CCM therapy and his outlook for the Optimizer Smart Mini system after the first implant. “Starting in 2019, we had the opportunity to implant Optimizer devices in several patients with heart failure. We believe in the technology and consider CCM therapy to be the only option for many patients suffering from heart failure. We are excited now to be affiliated with the first European institution to have implanted the new Optimizer Smart Mini device and look forward to the simple but more advanced patient management experiences during implants and follow-ups going forward.”

Dr. Giovani Bisignani, with the Ospedale di Castrovillari, who completed his first implant almost simultaneously in the southern Italian province of Cosenza, said, “CCM therapy is a powerful weapon against heart failure. The cutting-edge technology of the new Optimizer Smart Mini along with its smaller, physiological shape allowed us to achieve efficient implantation and initiation of CCM therapy in even less time.”

In March 2022, the company announced that its quality management system received certification under the new European Union Medical Device Regulation. We believe that the launch of the Optimizer Smart Mini system is an example of the importance of a global infrastructure to support ongoing technology innovation and access. The new components of the Optimizer Smart Mini system are equally important across international markets, including a rechargeable battery with a 20-year life and new internal technology with improved programming and potential for remote monitoring in a smaller design to make the implant procedure easier for patients and physicians.

“The pace of this international rollout is a reflection of our commitment to delivering innovation that is relevant to patients worldwide,” said Mateusz Zelewski, MD, Impulse Dynamics’ Vice President International, “It is exciting to see how quickly we can increase access to new and better technology that offers hope for more patients living with heart failure.”

The Optimizer Smart Mini delivers CCM therapy, which consists of electric pulses applied to the heart between heartbeats and serves to enhance the performance of cardiac muscular contraction, making the heart work more efficiently without increasing the heart rate or the oxygen consumption of the cardiac muscle. CCM therapy is currently indicated in Europe to reduce hospitalizations and improve physical exercise tolerance, quality of life, and functional status for a large population of patients with systolic heart failure who remain symptomatic despite guideline-directed medical therapy.

To date, CCM therapy has already been used to treat over 7,000 patients worldwide and is available in 44 countries across the globe. The therapy has been studied in almost 2,000 patients and has appeared in more than 100 peer-reviewed journal articles. Ongoing studies are also underway to examine the safety and efficacy of CCM for patients suffering from heart failure with a left ventricular ejection fraction between 40 – 60%.

About Impulse Dynamics

Impulse Dynamics is dedicated to helping healthcare providers enhance the lives of people with heart failure by transforming how the condition is treated. The company is focused on delivering its proprietary CCM therapy, which is delivered by the company’s Optimizer Smart device, the CE-marked, and FDA-approved treatment verified to improve the quality of life for heart failure patients. CCM therapy is a safe, effective, and minimally invasive treatment option for many heart failure patients who otherwise have few effective options available to them.[1] To learn more, visit www.ImpulseDynamics.com, or follow the company on LinkedIn, Twitter, and Facebook.

Forward-looking Statements

This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as ‘‘may,’’ ‘‘will,’’ ‘‘should,’’ ‘‘expect,’’ ‘‘plan,’’ ‘‘anticipate,’’ ‘‘could,’’ ‘‘intend,’’ ‘‘target,’’ ‘‘project,’’ ‘‘contemplate,’’ ‘‘believe,’’ ‘‘estimate,’’ ‘‘predict,’’ ‘‘potential’’ or ‘‘continue’’ or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements include, but are not limited to, statements concerning potential benefits of CCM therapy, and the absence of risks associated therewith; the ability for CCM therapy and our products to fill a significant unmet medical need for patients with heart failure; and the short-term and long-term benefits of the Optimizer Smart Mini and CCM therapy in patients with heart failure, as well as to the physicians treating those patients. These forward-looking statements are based on management’s current expectations and involve known and unknown risks and uncertainties that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Other important factors that could cause actual results, performance or achievements to differ materially from those contemplated in this press release include, without limitation: the company’s future research and development costs, capital requirements and the company’s needs for additional financing; commercial success and market acceptance of CCM therapy; the company’s ability to achieve and maintain adequate levels of coverage or reimbursement for Optimizer Smart and Optimizer Smart Mini systems or any future products the company may seek to commercialize; competitive companies and technologies in the industry; the company’s ability to expand its indications and develop and commercialize additional products and enhancements to its current products; the company’s business model and strategic plans for its products, technologies and business, including its implementation thereof; the company’s ability to expand, manage and maintain its direct sales and marketing organization; the company’s ability to commercialize or obtain regulatory approvals for CCM therapy and its products, or the effect of delays in commercializing or obtaining regulatory approvals; FDA or other U.S. or foreign regulatory actions affecting us or the healthcare industry generally, including healthcare reform measures in the United States and international markets; the timing or likelihood of regulatory filings and approvals; and the company’s ability to establish and maintain intellectual property protection for CCM therapy and products or avoid claims of infringement. The company does not undertake any obligation to update forward-looking statements and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. These forward-looking statements should not be relied upon as representing the company’s views as of any date subsequent to the date of this press release.

[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494150/

Attachments

Rex Richmond, Director (Media Relations)
Impulse Dynamics
856-642-9933
rrichmond@impulsedynamics.com

Harriss Currie, CFO (Investor Relations)
Impulse Dynamics
856-642-9933
hcurrie@impulsedynamics.com

Ian Segal, Public Relations
Impulse Dynamics
856-642-9933
isegal@impulsedynamics.com

Ankur Arora Named Product & Business Development Manager for Nikkiso Clean Energy and Industrial Gases Group

TEMECULA, Calif., June 14, 2022 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is pleased to announce that Ankur Arora has been named Product & Business Development Manager for Nikkiso Cryogenic Services serving Southeast Asia, New Zealand and Africa.

Ankur has broad global experience in over 30 countries and worked for nearly 20 years with Atlas Copco. His responsibilities included Business Development Manager and Global Sales & Marketing reporting to Germany, based in Auckland, New Zealand, Regional BDM & Application/Product Managers based in Shanghai. He has also served as Project Manager. A mechanical engineer, he also earned an MBA and is currently working on a DBA.

He will be responsible for the launch, sales and solutions related to Waste Heat Recovery and Organic Rankine Cycle Power Generation, Pressure Letdown Power Recovery and more. He will report to Emile Bado, Executive VP, Marketing, and Dr. Reza Agahi, Vice President of Turbo.

“Ankur’s industry and global market experience will be of great benefit to the Group, as we work to develop the opportunities in these regions,” according to Emile Bado, Executive Vice President, Marketing.

With this addition, Nikkiso continues their commitment to be both a global and local presence for their customers.

ABOUT CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (now a member of Nikkiso Co., Ltd.) member companies manufacture and service engineered cryogenic gas processing equipment (pumps, turboexpanders, heat exchangers, etc.), and process plants for Industrial Gases, Natural gas Liquefaction (LNG), Hydrogen Liquefaction (LH2) and Organic Rankine Cycle for Waste Heat Recovery. Founded over 50 years ago, Cryogenic Industries is the parent company of ACD, Nikkiso Cryo, Nikkiso Integrated Cryogenic Solutions, Cosmodyne and Cryoquip and a commonly controlled group of approximately 20 operating entities.

For more information, please visit www.nikkisoCEIG.com and www.nikkiso.com.

MEDIA CONTACT:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com